These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31391677)

  • 41. [Drug-induced hyperprolactinemia and galactorrhea].
    Bozzolo M; Haefeli WE; Noll G; Lüscher TF
    Schweiz Rundsch Med Prax; 1992 Dec; 81(50):1511-3. PubMed ID: 1465520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ineffectiveness of pyridoxine (B6) to alter secretion of growth hormone and prolactin and absence of therapeutic effects on galactorrhea-amenorrhea syndromes.
    Tolis G; Laliberté R; Guyda H; Naftolin F
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1197-9. PubMed ID: 559690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Galactorrhea and hyperprolactinemia during treatment of polycystic ovary syndrome.
    Wortsman J; Hirschowitz JS
    Obstet Gynecol; 1980 Apr; 55(4):460-3. PubMed ID: 6768040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Esomeprazole induced galactorrhea: a novel side effect.
    Pipaliya N; Solanke D; Rathi C; Patel R; Ingle M; Sawant P
    Clin J Gastroenterol; 2016 Feb; 9(1):13-6. PubMed ID: 26661629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antecedent factors and outcome in amenorrhea-galactorrhea.
    Rowe TC; Shearman RP; Fraser IS
    Obstet Gynecol; 1979 Nov; 54(5):535-43. PubMed ID: 574234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The mechanism of induction of ovulation by bromocriptine in euprolactinemic anovulation--the role of occult hyperprolactinemia in anovulation].
    Mori H; Aisaka K; Matsuoka R; Kigawa T
    Nihon Naibunpi Gakkai Zasshi; 1985 Jan; 61(1):38-47. PubMed ID: 3996685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of women with the galactorrhea-amenorrhea syndrome with pyridoxine (vitamin B6).
    McIntosh EN
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1192-5. PubMed ID: 945301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis and management of galactorrhea.
    Leung AK; Pacaud D
    Am Fam Physician; 2004 Aug; 70(3):543-50. PubMed ID: 15317441
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Galactorrhea in oral contraceptive users.
    Holtz G
    J Reprod Med; 1982 Apr; 27(4):210-2. PubMed ID: 7201522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of prolactin in human milk composition and serum lipids studied during suppression of galactorrhea with bromocriptine.
    Kandan S; Gopalakrishnan V; Govindarajulu P; Indira R; Malathi T
    Horm Res; 1983; 17(2):93-102. PubMed ID: 6682397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Galactorrhea during duloxetine treatment: a case report.
    Korkmaz S; Kuloğlu M; Işık U; Sağlam S; Atmaca M
    Turk Psikiyatri Derg; 2011; 22(3):200-1. PubMed ID: 21870310
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ziprasidone-induced galactorrhea: a case report.
    Kopecek M; Bares M; Mohr P
    Neuro Endocrinol Lett; 2005 Feb; 26(1):69-70. PubMed ID: 15726024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Galactorrhea and pituitary tumors in postpill and non-postpill secondary amenorrhea.
    March CM; Mishell DR; Kletzky OA; Israel R; Davajan V; Nakamura RM
    Am J Obstet Gynecol; 1979 May; 134(1):45-8. PubMed ID: 443307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Case-control study of galactorrhea and its relationship to the use of oral contraceptives.
    Taler SJ; Coulam CB; Annegers JF; Brittain EH
    Obstet Gynecol; 1985 May; 65(5):665-8. PubMed ID: 4039047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of nocturnal hyperprolactinemia on ovarian luteal function and galactorrhea.
    Yamaguchi M; Aono T; Koike K; Nishikawa Y; Ikegami H; Miyake A; Tanizawa O
    Eur J Obstet Gynecol Reprod Biol; 1991 May; 39(3):187-91. PubMed ID: 2032589
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Galactorrhea in DMPA users: incidence and clinical significance.
    Gongsakdi D; Rojanasakul A
    J Med Assoc Thai; 1986 Jan; 69(1):28-32. PubMed ID: 2937870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cimetidine-induced galactorrhea.
    Ehrinpreis MN; Dhar R; Narula A
    Am J Gastroenterol; 1989 May; 84(5):563-5. PubMed ID: 2719015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Galactorrhea and hyperprolactinemia in schizophrenic patients on neuroleptics: frequency and etiology.
    Windgassen K; Wesselmann U; Schulze Mönking H
    Neuropsychobiology; 1996; 33(3):142-6. PubMed ID: 8776743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Superiority of bromocriptine over pyridoxine in the treatment of patients with acromegaly or galactorrhea.
    Blum I; Segal S; Kaufman H; Sagiv M; Shalit M; Chowers I
    Isr J Med Sci; 1980 Jan; 16(1):12-6. PubMed ID: 7188934
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risperidone-induced galactorrhea associated with a prolactin elevation.
    Popli A; Gupta S; Rangwani SR
    Ann Clin Psychiatry; 1998 Mar; 10(1):31-3. PubMed ID: 9622047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.